Marl, Germany

Hans-Gerd Lueken

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Evonik Oxeno Gmbh, Evonik Degussa Gmbh, Degussa Aktiengesellschaft. Active years: 1990-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Gerd Lueken. Retrieved from https://idiyas.com/inventor/hans-gerd-lueken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 35.3


 

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 128(Granted Patents)


Company Filing History:


Years Active: 1990-2018

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Hans-Gerd Lueken: Pioneering Inventor from Marl

Introduction: Hans-Gerd Lueken is a distinguished inventor hailing from Marl, Germany, known for his groundbreaking contributions to the field of innovation.

Latest Patents: Hans-Gerd Lueken holds several patents in various industries, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning several decades, Hans-Gerd Lueken has consistently pushed the boundaries of what is possible through his inventive spirit and dedication to creating impactful technologies.

Collaborations: Throughout his career, Hans-Gerd Lueken has collaborated with leading companies, research institutions, and universities, fostering a culture of innovation and knowledge-sharing in the industry.

Conclusion: Hans-Gerd Lueken's legacy as an inventor is marked by his relentless pursuit of innovation and his commitment to shaping a better future through his groundbreaking inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…